CNO Financial Group, Inc.
CNO is a holding company for insurance subsidiaries that develop, market and administer health insurance, annuities, individual life insurance and other insurance and financial services products. It serves middle-income pre-retiree and retired Americans through exclusive agents, independent producers and direct marketing. Its primary brands are Bankers Life, Washington National and Colonial Penn. The Consumer Division serves individuals through phone, virtual, online and agent channels. The Worksite Division sells voluntary benefits, including supplemental health and life insurance, to businesses, associations and membership groups. CNO’s insurance products include fixed indexed and fixed interest annuities, supplemental health, Medicare supplement and long-term care insurance, and traditional and interest-sensitive life insurance. It earns income from insurance premiums and investment income; annuity income includes the spread between investment returns and amounts credited to policyholders. Its executive offices are in Carmel, Indiana.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $CNO in the last 30 days.
See all $CNO insider activity →CNO Financial Group (NYSE: CNO) declared a $0.18 quarterly dividend, its 59th consecutive. The dividend is payable December 23, 2026, to shareholders of record December 10, 2026. CNO offers insurance and financial services with $39.3B in total assets.
CNO Financial Group, Inc. (CNO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. AMENDMENT OF SECTION 382 RIGHTS AGREEMENT On November 13, 2026, CNO Financial Group, Inc. (the “ Company ”) entered into a Sixth Amended and Restated Section 382 Rights Agreement, dated November 13, 2026 (as the same may be am
CNO Financial Group reported Q3 2026 results with net income of $161M ($1.71 per share) and operating income of $179M ($1.90 per share). EPS grew 47% YoY, and the company raised full-year EPS guidance. Book value per share increased 8% to $41.29. CNO also completed a reinsurance transaction and repurchased $60M in common stock.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning CNO (CNO Financial Group, Inc.). Coverage has skewed bullish: 1 bullish, 2 neutral, and 0 bearish.
Recent CNO coverage spans earnings, corporate actions and financial news.
The dividend announcement may provide modest upside as income‑focused investors price in the new payout.
The amendment may affect tax loss carryforward protection and could influence shareholder dilution risk.
Positive earnings beat and guidance raise suggest near‑term upside.
Insider sale may signal limited confidence and could exert slight downward pressure.
A small insider sale adds modest supply to the market and may signal limited confidence from the officer.
AlphAI scores every news story that mentions CNO with an AI model for sentiment and relevance, and aggregates insider trades from CNO Financial Group, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
CNO Financial Group (NYSE: CNO) declared a $0.18 quarterly dividend, its 59th consecutive. The dividend is payable December 23, 2026, to shareholders of record December 10, 2026. CNO offers insurance and financial services with $39.3B in total assets.
CNO Financial Group, Inc. (CNO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. AMENDMENT OF SECTION 382 RIGHTS AGREEMENT On November 13, 2026, CNO Financial Group, Inc. (the “ Company ”) entered into a Sixth Amended and Restated Section 382 Rights Agreement, dated November 13, 2026 (as the same may be am
CNO Financial Group reported Q3 2026 results with net income of $161M ($1.71 per share) and operating income of $179M ($1.90 per share). EPS grew 47% YoY, and the company raised full-year EPS guidance. Book value per share increased 8% to $41.29. CNO also completed a reinsurance transaction and repurchased $60M in common stock.
CNO Financial Group's Chief Actuary, Jeremy D. Williams, sold 8,782 shares ($487,321) and acquired 7,660 shares ($168,674) via options. CNO reported Q2 2026 earnings of $1.26 per share, beating estimates, and raised its full-year profit outlook. Texas Capital Securities initiated coverage with a Buy rating and $70 target. CNO trades near its 52-week high.
CNO Financial Group (CNO) officer Jeremy Williams plans to sell 4,420 shares, valued at $244,291.63, on September 15, 2026, following a stock option exercise. The sale is under Rule 144, which governs insider stock sales.
CNO Financial Group (CNO) reported Q2 revenue beating expectations, with operating earnings per share up 45% and 16 consecutive quarters of sales growth. The stock is up 30.19% year-to-date and 42.14% over one year. However, it is slightly overvalued according to a narrative fair value of $53.50. Growth is driven by annuity and life/health policy sales, digital channels, and an aging U.S. population. Risks include low long-term interest rates and rising long-term care claims.
CNO Financial Group (CNO) fell 5.1% post-earnings, trading at $49.44. Brighthouse Financial (BHF) reported $2.10B revenue, down 2.4% YoY, missing estimates, and dropped 15.3% to $52.42. Aflac (AFL) reported $4.22B revenue, down 6.9% YoY, in line with expectations, and fell 9.4% to $114.77. The market has shifted focus from AI to geopolitics and back to fundamentals.
CNO Financial Group (CNO) is expanding in worksite and Medicare insurance markets. The company highlights growth opportunities in geographic expansion, new group development, and agent productivity. CNO has paid nearly $5 billion to policyholders through return-of-premium features. Medicare Supplement policies sold increased by over 18% annually since 2023, with in-force policies reaching 212,000 in 2026. CNO expects Medicare Supplement margins to improve to historical levels in 2026.
Linnenbringer Jeanne L. (Chief Operations Officer) sold 14,539 shares of CNO Financial Group, Inc. (CNO) at an average of $54.95 ($54.73–$55.11, $0.80M total) across 4 trades over 2026-08-31 to 2026-09-02 under a Rule 10b5-1 trading plan.
DeToro Karen J. (President, Worksite Division) sold 24,674 shares of CNO Financial Group, Inc. (CNO) at an average of $54.92 ($54.73–$55.12, $1.36M total) across 5 trades over 2026-08-31 to 2026-09-02 under a Rule 10b5-1 trading plan.
